CRP and ankylosing spondylitis: The observed differences in age of onset, elevated levels of inflammatory markers such as C-reactive protein, and the higher incidence of ankylosing spondylitis in the HLA-B27-positive group underscore the importance of this biomarker in patient stratification and the personalisation of therapeutic management.